InsidersTradesSigma
Follow the 오리엔트바이오 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 오리엔트바이오 has logged 3 insider filings. Market capitalisation: €63.4bn. The latest transaction was filed on 20 March 2026 (Purchase). Among the most active insiders: 오리엔트. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Orient Bio is a company operating in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development of biological products and diagnostic solutions.